What is Rigel Pharmaceuticals's free cash flow margin?

Rigel Pharmaceuticals (RIGL) reported free cash flow margin of -61.7% in Q4 2022.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Rigel Pharmaceuticals RIGL Free cash flow margin

Discontinued — last reported Q4 '22

Free cash flow margin at other companies

AmgenAMGN

23.1%-8.9pp

Agios PharmaceuticalsAGIO

-582.5%-185pp

Nuvation BioNUVB

-93.5%-45.2pp

Zevra Therapeutics, Inc.ZVRA

-75%-30.5pp

Gyre Therapeutics, Inc.GYRE

2.6%—

Eton Pharmaceuticals, Inc.ETON

17.1%—

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Calculated from Rigel Pharmaceuticals’s reported figures.

free cash flow/total revenue=-61.7%

Based on trailing twelve months.

The official record: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's free cash flow margin?: Rigel Pharmaceuticals (RIGL) reported free cash flow margin of -61.7% in Q4 2022.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.